Compare iShares MSCI Australia ETF (EWA) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Australia ETF vs Stryker Corporation — how do they compare? iShares MSCI Australia ETF trades at $28.62 (market cap $1.17B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 90.8× iShares MSCI Australia ETF's market cap, and Stryker Corporation pays a 1.27% dividend while iShares MSCI Australia ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Australia ETF for 61 Days and Stryker Corporation for 21 Days on average.
| EWA | SYK | |
|---|---|---|
Market Cap | $1.17B | $106.24B |
Volume | 2,121,231 | 2,982,001 |
Sector | Broad Market / Factor | Health |
52-Week High | $30.43 | $388.35 |
52-Week Low | $24.95 | $269.75 |
Typical Hold Time | 61 Days | 21 Days |
Enterprise Value | — | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The iShares MSCI Australia ETF (EWA) trades at $28.23, showing no change over the past 24 hours. Technical indicators are predominantly bearish, with moving averages signaling a sell and oscillators neutral. Recent news highlights institutional selling by Squarepoint Ops LLC and broader Australian market pressures from inflation concerns, though some analysts see upside potential tied to commodity exposure.
The outlook is mixed; EWA offers exposure to Australia's commodity-driven economy with potential for gains if raw material prices rise, but faces headwinds from inflation and monetary policy tightening. Key risks include economic sensitivity to global demand and market volatility. Analyst sentiment is divided, with some targeting over 20% upside.
Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.
Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Australia ETF
EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
